ZURZUVAE Trademark

Trademark Overview

On Tuesday, March 22, 2022, a trademark application was filed for ZURZUVAE with the United States Patent and Trademark Office. The USPTO has given the ZURZUVAE trademark a serial number of 97325024. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, March 8, 2024. The ZURZUVAE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
zurzuvae

General Information

Serial Number97325024
Word MarkZURZUVAE
Filing DateTuesday, March 22, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, March 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 28, 2022
Primary Code005
First Use Anywhere DateTuesday, December 5, 2023
First Use In Commerce DateTuesday, December 5, 2023

Trademark Owner History

NOT AVAILABLE

Trademark Events

Event DateEvent Description
Saturday, March 9, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 6, 2024USE AMENDMENT FILED
Thursday, February 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 6, 2024TEAS STATEMENT OF USE RECEIVED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 24, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 24, 2023SOU EXTENSION 1 FILED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 3, 2023ASSIGNED TO EXAMINER
Monday, March 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 25, 2022NEW APPLICATION ENTERED

Related Keywords

zurzuvae depression disorders anxiety disorder bipolar diseases system preparations treatment central